{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Parnate", "query": { "intervention": "Parnate" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 11, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Parnate&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-03T22:57:18.477Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00021528", "title": "Sequenced Treatment Alternatives to Relieve Depression (STAR*D)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Depression" ], "interventions": [ { "name": "citalopram", "type": "DRUG" }, { "name": "BuproprionSR", "type": "DRUG" }, { "name": "buspirone", "type": "DRUG" }, { "name": "Lithium", "type": "DRUG" }, { "name": "mirtazapine", "type": "DRUG" }, { "name": "nortriptyline", "type": "DRUG" }, { "name": "sertraline", "type": "DRUG" }, { "name": "tranylcypromine", "type": "DRUG" }, { "name": "VenlafaxineXR", "type": "DRUG" }, { "name": "Cognitive Therapy", "type": "BEHAVIORAL" }, { "name": "T3 (Triiodothyronine)", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "National Institute of Mental Health (NIMH)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 4000, "start_date": "2001-07", "completion_date": "2006-09", "has_results": false, "last_update_posted_date": "2009-09-25", "last_synced_at": "2026-09-03T22:57:18.477Z", "location_count": 41, "location_summary": "Birmingham, Alabama • Tuscaloosa, Alabama • Chula Vista, California + 20 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Chula Vista", "state": "California" }, { "city": "Harbor City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00021528" }, { "nct_id": "NCT01031810", "title": "PET Biomarkers in Treatment Resistant Depression", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "tranylcypromine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "New York State Psychiatric Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 13, "start_date": "2009-11", "completion_date": "2013-03", "has_results": true, "last_update_posted_date": "2014-09-18", "last_synced_at": "2026-09-03T22:57:18.477Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01031810" }, { "nct_id": "NCT01944657", "title": "Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "1. Major Depressive Disorder" ], "interventions": [ { "name": "Supplemental TMS", "type": "DEVICE" }, { "name": "Standard Medication Monotherapy", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Sheppard Pratt Health System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 0, "start_date": "2013-09", "completion_date": "2015-12", "has_results": false, "last_update_posted_date": "2017-04-25", "last_synced_at": "2026-09-03T22:57:18.477Z", "location_count": 1, "location_summary": "Towson, Maryland", "locations": [ { "city": "Towson", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01944657" }, { "nct_id": "NCT00177567", "title": "Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "lithium carbonate", "type": "DRUG" }, { "name": "Depakote-ER", "type": "DRUG" }, { "name": "risperidone", "type": "DRUG" }, { "name": "olanzapine", "type": "DRUG" }, { "name": "paroxetine", "type": "DRUG" }, { "name": "bupropion", "type": "DRUG" }, { "name": "lamotrigine", "type": "DRUG" }, { "name": "venlafaxine", "type": "DRUG" }, { "name": "tranylcypromine", "type": "DRUG" }, { "name": "mirtazapine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 60, "start_date": "2001-07", "completion_date": "2004-01", "has_results": false, "last_update_posted_date": "2005-09-15", "last_synced_at": "2026-09-03T22:57:18.477Z", "location_count": 2, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00177567" }, { "nct_id": "NCT00012558", "title": "Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "lithium", "type": "DRUG" }, { "name": "valproate", "type": "DRUG" }, { "name": "bupropion", "type": "DRUG" }, { "name": "paroxetine", "type": "DRUG" }, { "name": "lamotrigine", "type": "DRUG" }, { "name": "risperidone", "type": "DRUG" }, { "name": "inositol", "type": "DRUG" }, { "name": "tranylcypromine", "type": "DRUG" }, { "name": "Cognitive Behavioral Therapy", "type": "BEHAVIORAL" }, { "name": "Family-focused Therapy", "type": "BEHAVIORAL" }, { "name": "Interpersonal and Social Rhythms Therapy", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "National Institute of Mental Health (NIMH)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": null, "sex": "ALL", "summary": "15 Years and older" }, "enrollment_count": 5000, "start_date": "1998-09", "completion_date": "2005-09", "has_results": false, "last_update_posted_date": "2007-05-04", "last_synced_at": "2026-09-03T22:57:18.477Z", "location_count": 11, "location_summary": "Stanford, California • Denver, Colorado • Boston, Massachusetts + 8 more", "locations": [ { "city": "Stanford", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Worcester", "state": "Massachusetts" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00012558" }, { "nct_id": "NCT00612807", "title": "Treatment of Mood and Marriage Study (TOMMS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Major Depressive Disorder", "Partner Relational Disorder (V61.10)" ], "interventions": [ { "name": "Weekly marital therapy", "type": "BEHAVIORAL" }, { "name": "As indicated: Sertraline, bupropion, venlafaxine, mirtazepine, nortriptyline, tranylcypromine, lithium augmentation, etc.", "type": "DRUG" } ], "intervention_types": [ "BEHAVIORAL", "DRUG" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 42, "start_date": "2006-07", "completion_date": "2010-06", "has_results": true, "last_update_posted_date": "2013-06-24", "last_synced_at": "2026-09-03T22:57:18.477Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00612807" }, { "nct_id": "NCT00296686", "title": "Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Major Depression" ], "interventions": [ { "name": "Tranylcypromine", "type": "DRUG" }, { "name": "Dextroamphetamine", "type": "DRUG" }, { "name": "Triiodothyronine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "New York State Psychiatric Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 31, "start_date": "2001-09", "completion_date": "2006-08", "has_results": false, "last_update_posted_date": "2012-04-27", "last_synced_at": "2026-09-03T22:57:18.477Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00296686" }, { "nct_id": "NCT02273102", "title": "Study of TCP-ATRA for Adult Patients With AML and MDS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Acute Myelogenous Leukemia", "Myelodysplastic Syndromes", "Leukemia" ], "interventions": [ { "name": "Tranylcypromine", "type": "DRUG" }, { "name": "Tretinoin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 17, "start_date": "2015-03-02", "completion_date": "2020-07-01", "has_results": false, "last_update_posted_date": "2020-07-21", "last_synced_at": "2026-09-03T22:57:18.477Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02273102" }, { "nct_id": "NCT00223691", "title": "Treatment of Orthostatic Hypotension in Autonomic Failure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Autonomic Failure", "Orthostatic Hypotension" ], "interventions": [ { "name": "Atomoxetine", "type": "DRUG" }, { "name": "Acarbose", "type": "DRUG" }, { "name": "Pyridostigmine Bromide", "type": "DRUG" }, { "name": "Yohimbine", "type": "DRUG" }, { "name": "Midodrine HCl", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "Modafinil", "type": "DRUG" }, { "name": "Octreotide", "type": "DRUG" }, { "name": "water intake", "type": "OTHER" }, { "name": "Diphenhydramine Hydrochloride", "type": "DRUG" }, { "name": "Ranitidine HCL", "type": "DRUG" }, { "name": "Tranylcypromine", "type": "DRUG" }, { "name": "Ergotamine/ Caffeine", "type": "DRUG" }, { "name": "Celecoxib", "type": "DRUG" }, { "name": "Pseudoephedrine", "type": "DRUG" }, { "name": "Methylphenidate", "type": "DRUG" }, { "name": "Indomethacin", "type": "DRUG" }, { "name": "Ibuprofen", "type": "DRUG" }, { "name": "Oxymetazoline 0.05% nasal solution", "type": "DRUG" }, { "name": "Bovril", "type": "DIETARY_SUPPLEMENT" }, { "name": "Acetazolamide", "type": "DRUG" }, { "name": "Rivastigmine tartrate", "type": "DRUG" }, { "name": "Carbidopa/levodopa", "type": "DRUG" }, { "name": "Inflatable abdominal binder", "type": "DEVICE" }, { "name": "inflatable abdominal binder (sham)", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "OTHER", "DIETARY_SUPPLEMENT", "DEVICE" ], "sponsor": "Vanderbilt University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 389, "start_date": "2002-03", "completion_date": "2017-01", "has_results": false, "last_update_posted_date": "2017-01-18", "last_synced_at": "2026-09-03T22:57:18.477Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00223691" }, { "nct_id": "NCT00653393", "title": "Bioavailability Study of Tranylcypromine 10mg Tablets Under Fasting Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "To Determine the Bioavailability of Tranylcypromine" ], "interventions": [ { "name": "Tranylcypromine", "type": "DRUG" }, { "name": "Parnate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Par Pharmaceutical, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 39, "start_date": "2004-10", "completion_date": "2004-12", "has_results": false, "last_update_posted_date": "2008-04-04", "last_synced_at": "2026-09-03T22:57:18.477Z", "location_count": 1, "location_summary": "Fort Myers, Florida", "locations": [ { "city": "Fort Myers", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00653393" } ] }